MedTrace Logo

Myocardial Involvement of Severe Acute Respiratory Syndrome-Cov-2 (Covid19) Infected Patients

NCT04358952 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 122

Last updated 2021-06-01

No results posted yet for this study

Summary

The effects of severe acute respiratory syndrome SARS-Cov-2 (Covid-19) on the myocardium and their role in the clinical course of infected patients are still unknown. Epidemiological studies report biological myocardial involvement in 10 to 25% of cases. The objective of this study is to cardiac phenotype using comprehensive cardiac imaging tools of patients infected with Covid 19 in order to explore the functional impact of the infection on the myocardium.

Conditions

  • Cardiomyopathies

Interventions

DIAGNOSTIC_TEST

Global Longitudinal Strain

Electrocardiogram with measure of the Global Longitudinal Strain to evaluate myocardiac dysfunction

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Vincent MINVILLE, PU-PH · University Hospital, Toulouse

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-04
Primary Completion
2021-04-02
Completion
2021-04-02

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04358952 on ClinicalTrials.gov